MacPherson, Amanda
Kimmelman, Jonathan
Article History
Received: 30 October 2018
Accepted: 4 June 2019
First Online: 3 July 2019
Competing interests
: J.K. serves on a Data and Safety Monitoring Board in a remunerative capacity for Ultragenyx Inc. The trial involves a gene therapy (not a stem-cell-based intervention). Compensation is <10K USD/year.